Clin2
NCT06522100Possibly a fitNot yet recruiting

Steroid treatment for acute heart muscle inflammation

Acute Myocarditis

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether steroids (corticoids) can improve recovery in people with acute myocarditis, which is inflammation of the heart muscle. If you have been recently diagnosed and your heart isn't pumping as well as it should, this treatment might help reduce inflammation and improve heart function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
420 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have a confirmed diagnosis of acute myocarditis (inflammation of the heart muscle).
  • Your heart's pumping ability must be slightly reduced (ejection fraction below 50% or a similar measure).
  • You need to have had a heart artery check (coronary angiography or CT) within the last year showing no significant blockages.
  • You cannot have certain other causes of heart inflammation (like giant cell myocarditis or sarcoidosis) that need different treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05974462Recruiting· Phase 3
Steroids for mild heart inflammation with weaker pumping

This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.

Edegem, Antwerp
NCT05855746Recruiting· Phase 3
Colchicine vs placebo for acute myocarditis

This trial tests whether colchicine (a medicine that reduces inflammation) improves outcomes in people with acute myocarditis soon after symptoms start. Half of participants get colchicine and half get a placebo to see which works better.

Bron
NCT05150704Recruiting· Phase 3
Steroid treatment for suspected acute myocarditis in hospital

This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.

San Diego, California
NCT06896253Not yet recruiting· Phase 2
Steroids or immunoglobulins for severe sudden heart inflammation

This trial tests whether giving steroids, immunoglobulins, or both can help people with a sudden, severe heart muscle inflammation (myocarditis) that causes shock or dangerous heart rhythms. The goal is to see if these treatments improve recovery compared to standard care.

NCT06686862Recruiting· Phase 3
Anti-inflammatory drugs for acute myocarditis

This trial tests if non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, help people with acute myocarditis (inflammation of the heart muscle) who are hospitalized but have normal heart function. It aims to see if these drugs can reduce inflammation and improve recovery.

Majadahonda, Madrid
NCT06635863Enrolling by invitation· Phase 4
Steroids versus standard heart medications for heart inflammation

This study compares two treatment strategies for people with unexplained heart failure and irregular heartbeats caused by inflammation: one group gets standard heart medications plus an immune-suppressing steroid (prednisone), and the other gets standard medications alone. Doctors want to see whether adding steroids helps improve heart function and control dangerous heart rhythms.

Phoenix, Arizona

Hear when a new Acute Myocarditis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.